These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33957960)

  • 1. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
    Mohammed BAB
    J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
    Aoki N; Saito H; Kamiya T; Koie K; Sakata Y; Kobakura M
    J Clin Invest; 1979 May; 63(5):877-84. PubMed ID: 156196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency.
    Kordich L; Feldman L; Porterie P; Lago O
    Thromb Res; 1985 Dec; 40(5):645-51. PubMed ID: 4089832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
    Kluft C; Vellenga E; Brommer EJ; Wijngaards G
    Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
    Miles LA; Plow EF; Donnelly KJ; Hougie C; Griffin JH
    Blood; 1982 Jun; 59(6):1246-51. PubMed ID: 7082827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.
    Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M
    Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
    Dewerchin M; Collen D; Lijnen HR
    Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
    Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
    Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited disorders of the fibrinolytic pathway.
    Jain S; Acharya SS
    Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.
    Takahashi R; Ono K; Ikeda T; Akagi A; Noto D; Nozaki I; Sakai K; Asakura H; Iwasa K; Yamada M
    Amyloid; 2012 Sep; 19(3):129-32. PubMed ID: 22624582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
    Nielsen VG; Ellis TC
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
    Sakata Y; Aoki N
    J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene targeting in hemostasis. Alpha2-antiplasmin.
    Lijnen HR
    Front Biosci; 2001 Feb; 6():D239-47. PubMed ID: 11171550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory evaluation of patients with undiagnosed bleeding disorders.
    Alves GS; Orsi FA; Santiago-Bassora FD; Quaino SK; Montalvão SA; Paula EV; Annichino-Bizzacchi JM
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):500-5. PubMed ID: 26825625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.